Identifying Alzheimer’s development in Type 2 diabetes mellitus patients

Type 2 diabetes mellitus (T2DM) is an age-associated disorder, with T2DM patients also exhibiting a significantly increased risk of Alzheimer’s disease. Identifying biomarkers that can successfully predict the conversion of T2DM into Alzheimer’s disease may therefore provide an efficient method for initiating early intervention for patients. This was the basis of a new study published recently in EBioMedicine by researchers from Huazhong University of Science and Technology (Hubei, China). Jian-Zhi Wang (Huazhong University of Science and Technology), lead author of the study, explained their belief that current diagnostics for Alzheimer’s disease are reliant on often subjective cognitive tests or expensive...